These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


236 related items for PubMed ID: 2444504

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibitors of coagulation-fibrinolysis system and platelet function in patients with vertigo.
    Noda Y, Nakamura M, Sasaki M, Kosugi T.
    Auris Nasus Larynx; 1986; 13 Suppl 1():S75-9. PubMed ID: 2429647
    [Abstract] [Full Text] [Related]

  • 3. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.
    Glueck CJ, Glueck HI, Stroop D, Speirs J, Hamer T, Tracy T.
    J Lab Clin Med; 1993 Oct; 122(4):412-20. PubMed ID: 8228555
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. On fibrinolysis in diabetes mellitus.
    Almér LO, Nilsson IM.
    Acta Med Scand; 1975 Oct; 198(1-2):101-6. PubMed ID: 52286
    [Abstract] [Full Text] [Related]

  • 9. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction.
    Van de Werf F, Ludbrook PA, Bergmann SR, Tiefenbrunn AJ, Fox KA, de Geest H, Verstraete M, Collen D, Sobel BE.
    N Engl J Med; 1984 Mar 08; 310(10):609-13. PubMed ID: 6537987
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regional fibrinolytic study in coronary artery disease.
    Patrassi GM, Bisetti P, Chioin R, Procidano M, Girolami A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982 Jun 30; 109(2):307-12. PubMed ID: 6179833
    [Abstract] [Full Text] [Related]

  • 13. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C, Barton MH, Prasse KW, Moore JN.
    J Am Vet Med Assoc; 1995 Aug 15; 207(4):465-70. PubMed ID: 7591947
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The pathogenesis of accelerated fibrinolysis in hepatosplenic schistosomiasis.
    Omran SA, Madkour BA, Essawy FM, Toima SM, el Kaliouby AH, Shams el Din AA.
    Blood Coagul Fibrinolysis; 1992 Dec 15; 3(6):819-22. PubMed ID: 1489902
    [Abstract] [Full Text] [Related]

  • 18. Factors affecting coagulation: fibrinolysis in chronic subdural fluid collections.
    Weir B, Gordon P.
    J Neurosurg; 1983 Feb 15; 58(2):242-5. PubMed ID: 6848682
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Proteolysis of fibrinogen in healthy volunteers following major and minor vivo plasminogen activation.
    Prowse CV, Dawes J, Lane DA, Ireland H, Knight I.
    Thromb Res; 1982 Jul 01; 27(1):91-7. PubMed ID: 6750837
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.